Skip to main content

AnewHealth Announces Strategic Investment from The Vistria Group and Acquisition of HomeFree

AnewHealth will merge HomeFree with its national medication management and pharmacy provider, ExactCare, to further amplify its focus on improving clinical and cost outcomes for the most complex patients in healthcare

CLEVELAND, OH and MOORESTOWN, NJ, July 22, 2024 (GLOBE NEWSWIRE) — AnewHealth, a national pharmacy care management provider that improves healthcare outcomes for people with complex, chronic medical needs, today announced the company’s acquisition of HomeFree Pharmacy Services. With the closing of this transaction, HomeFree has become part of the AnewHealth suite of comprehensive at-home pharmacy solutions, which has been purposefully designed to transform the role of pharmacy in managing clinical and cost outcomes for the most complex patients in the healthcare system.

AnewHealth collaborates with healthcare organizations to reach these complex patients and has well-established, long-standing partnerships with many of the top home health providers, primary and specialty care providers, risk-bearing organizations like PACE, and managed care plans. The company’s robust suite of solutions—which includes comprehensive clinical pharmacy care and national medication dispensing, MedWise® science-based technology to personalize medication regimens, and full-service pharmacy benefit management—helps partners achieve clinical, quality and financial goals including improved adherence, reduced unplanned facility utilization, lower all-cause mortality rates, reduced medical expenditures, and lower total cost of care.

“At AnewHealth, we firmly believe that to successfully manage more complex health needs, the delivery of pharmacy care has to evolve beyond being a transactional experience,” said John Figueroa, CEO of AnewHealth. “That’s why HomeFree is such a natural fit for us. By combining the established expertise of HomeFree and ExactCare, we will further strengthen our dedication to delivering a comprehensive level of pharmacy and medication-related care for those patients we know require enhanced support to safely manage their health at home—which is where they want to be and where their healthcare providers want them to be, as long as possible. We will take best practices from both organizations to expand and enhance the care that we provide.”

Today, HomeFree serves nearly 5,000 patients in 33 states and has strong partnerships with a number of national home health providers. With the addition of HomeFree, AnewHealth serves nearly 110,000 patients nationwide, with established facility capacity for immediate growth to expand care for the millions nationwide who need access to in-home medication support to maintain their health, avoid unplanned hospital and ER visits, and thrive in the home-based settings of their choice.

“We know that a more comprehensive approach to pharmacy care is more effective for these complex populations, and AnewHealth has demonstrated that impact through measurable improvements in adherence, reductions in avoidable healthcare utilization, and lower total cost of care,” said Brian Adams, President, AnewHealth. “Beyond that, patients who receive pharmacy services delivered through AnewHealth have clearly and consistently validated the value of this elevated care experience through Net Promoter Score ratings that far surpass traditional pharmacy care models and rank world-class by industry standards. This business combination will only strengthen our ability to make a difference for the people who need it most.”

In connection with this business combination, The Vistria Group (“Vistria”) has become a minority investor of AnewHealth. Vistria is a next-generation private investment firm with expertise in healthcare and a focus on partnering with organizations that deliver lasting societal impact. David Schuppan, Senior Partner and Co-Head of Healthcare at Vistria, and Chris Hocevar, Chief Executive Officer of Help at Home, have joined the AnewHealth board. Nautic Partners, a leading middle market private investment firm, is the controlling owner of AnewHealth and has been since 2016. Over the course of Nautic’s ownership, AnewHealth has grown patients on service more than 500 percent.

About AnewHealth
AnewHealth is one of the nation’s leading pharmacy care management companies that specializes in caring for people with the most complex, chronic needs—wherever they call home. The company enables better health and quality of life for patients while helping the healthcare organizations who support them improve key clinical and cost outcomes. Established in 2023 through the combination of ExactCare Pharmacy and Tabula Rasa HealthCare, AnewHealth provides a suite of solutions that includes comprehensive pharmacy services with national dispensing; proprietary science-based technology to optimize medication therapy; full-service pharmacy benefit management; and specialized support services for PACE (Program of All-Inclusive Care for the Elderly). Today, AnewHealth cares for nearly 110,000 people nationwide through strong healthcare partnerships with risk-bearing providers, primary and specialty care providers, kidney care and dialysis providers, home health organizations, and managed care plans. For more info, visit our website: anewhealthrx.com

CONTACT: Contact:
Sandy McKenzie, Director of Corporate Communications, AnewHealth
SMcKenzie@anewhealthrx.com
Kara Slater, VP of Marketing, AnewHealth
KSlater@ExactCarePharmacy.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.